v3.26.1
Segmentation of key figures (Tables)
 6 Months Ended
Jun. 30, 2026
Operating Segments [Abstract]  
Disclosure of segment information
Net sales and other revenues by segment
Three months ended June 30Six months ended June 30
($ millions)2026202520262025
Surgical
Implantables466 456 904 876 
Consumables825 777 1,594 1,489 
Equipment/other279 222 532 421 
Total Surgical net sales1,570 1,455 3,030 2,786 
Vision Care
Contact lenses726 692 1,464 1,380 
Ocular health486 430 973 862 
Total Vision Care net sales1,212 1,122 2,437 2,242 
Total net sales2,782 2,577 5,467 5,028 
Surgical other revenues1 — 2 1 
Vision Care other revenues
40 19 60 40 
Total other revenues41 19 62 41 
Total net sales and other revenues2,823 2,596 5,5295,069 
Segment contribution and reconciliation to (loss)/income before taxes
The below table summarizes segment contribution, including material items of income and expense and includes a reconciliation of segment contribution to (Loss)/income before taxes.
SurgicalVision CareNot allocated to segmentsTotal
Three months ended June 30
Three months ended June 30
Three months ended June 30
Three months ended June 30
($ millions)20262025202620252026202520262025
Net sales1,570 1,455 1,212 1,122 — — 2,782 2,577 
Other revenues1 — 40 19 — — 41 19 
Cost of net sales(600)(553)(393)(416)(137)(227)(1,130)(1,196)
Cost of other revenues(1)— (17)(12)— — (18)(12)
Selling, general & administration(428)(372)(455)(415)(81)(83)(964)(870)
Research & development(150)(152)(104)(90)(409)(3)(663)(245)
Other income— — — — 6 5 6 5 
Other expense— — — — (43)(31)(43)(31)
Segment contribution and Operating income392 378 283 208 (664)(339)11 247 
Interest expense(53)(51)(53)(51)
Other financial income & expense— 4 — 4 
Share of loss from associated companies(4)(1)(4)(1)
(Loss)/income before taxes(46)199 
SurgicalVision CareNot allocated to segmentsTotal
Six months ended June 30
Six months ended June 30
Six months ended June 30
Six months ended June 30
($ millions)20262025202620252026202520262025
Net sales3,030 2,786 2,437 2,242 — — 5,467 5,028 
Other revenues2 1 60 40 — — 62 41 
Cost of net sales(1,163)(1,049)(816)(813)(314)(405)(2,293)(2,267)
Cost of other revenues(2)(1)(34)(30)— — (36)(31)
Selling, general & administration(814)(728)(869)(788)(163)(167)(1,846)(1,683)
Research & development(294)(295)(201)(162)(413)(10)(908)(467)
Other income— — — — 17 154 17 154 
Other expense— — — — (160)(60)(160)(60)
Segment contribution and Operating income759 714 577 489 (1,033)(488)303 715 
Interest expense(105)(100)(105)(100)
Other financial income & expense2 13 2 13 
Share of loss from associated companies(6)(15)(6)(15)
Income before taxes194 613 
Disclosure of net sales by region
Net sales by region(1)
Three months ended June 30Six months ended June 30
($ millions unless indicated otherwise)2026202520262025
United States1,241 45 %1,160 45 %2,469 45 %2,297 46 %
International1,541 55 %1,417 55 %2,998 55 %2,731 54 %
Net sales2,782 100 %2,577 100 %5,467 100 %5,028 100 %
(1)     Net sales by location of third-party customer.